Skip to main content

Beacon Pointe Advisors, LLC

SEC CIK
0001744317
Latest filing
Aug 18, 2026

MDGL holding history

Madrigal Pharmaceuticals, Inc. in every 13F filed by Beacon Pointe Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MDGL overviewAll 13F holders of MDGLFull Q2 2026 holdings

Shares (Q2 2026)
966
Value
$518.7K
% of portfolio
<0.1%
Quarters held
1
Since Q2 2026
Holdings of MDGL by Beacon Pointe Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026966$518.7K<0.1%+966NewHolders